FOXP3 and cancer: FOXP3+ T cells are common regulators of cytotoxic T-cell responses, and high levels of peripheral CD4+CD25+FOXP3+ regulatory T cells have been associated with poor clinical response to adoptive cell therapy in human cancer (70).